Ginkgo Bioworks Holdings Q2 2024 GAAP EPS $(0.11) Misses $(0.07) Estimate, Sales $56.21M Beat $43.14M Estimate
Ginkgo Bioworks Holdings Q2 2024 GAAP EPS $(0.11) Misses $(0.07) Estimate, Sales $56.21M Beat $43.14M Estimate
Ginkgo Bioworks Holdings 2024年第二季度的营业额为5621万美元，超过预期的4314万美元。每股收益为$(0.11)，低于预期的$(0.07)。
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. The company reported quarterly sales of $56.21 million which beat the analyst consensus estimate of $43.14 million by 30.30 percent. This is a 30.24 percent decrease over sales of $80.57 million the same period last year.
Ginkgo Bioworks Holdings（纽交所：DNA）报告每股亏损0.11美元，比分析师共识预期的0.07美元亏损率高达57.14％。该公司报告季度销售额为5621万美元，比分析师共识预期的4314万美元高出30.30％。这是自去年同期销售额为8057万美元以来的下降30.24％。
资讯热榜
更新时间